Skip to content

Stepan SCL Specialty Products — Operating Income

Other segment segments

Surfactants
$18.55M-35.9%
Polymers
$8.82M+10.0%

Similar metrics at other companies

Balchem logo
BCPCSpecialty Products — Operating Income (Loss)
$11.94M+24.5%
Chart Industries logo
GTLSSpecialty Products — Operating Income (Loss)
$8.4M-82.6%
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Operating Income (Loss)
$50.06M+234%
APi Group logo
APGSpecialty Services — Operating Income (Loss)
$39M+34.5%
Henry Schein logo
HSICGlobal Specialty Products — Operating Income
$58M+3.6%
Trimas logo
TRSSpecialty Products — Segment adjusted operating profit
$2.86M+349%

Other financials

Income statement

See full
Revenue$604.5M+1.9%
Gross profit$64.9M-14.1%
Operating income-$49.6M-275%
Net income-$41.4M-310%
EPS (diluted)-$1.81-310%

Balance sheet

See full
Cash & equivalents$140.8M+31.0%
Total debt$713.1M-2.5%
Total equity$1.2B-0.6%
Total assets$2.3B-2.4%

Cash flow

See full
Operating cash flow$16.9M+144%
CapEx$30.9M-5.7%
Free cash flow-$14.0M+45.9%

Valuation

See full
Market cap$1.25B+3.0%
Enterprise value$1.82B-0.8%
P/S0.5×0.0×

Profitability

See full
Gross margin11.1%-1.4pp
Operating margin0%-3.5pp
Net margin-0.6%-3.1pp
FCF margin1.6%

Returns & leverage

See full
Return on equity-1.2%-5.8pp
Debt / equity0.6×0.0×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Stepan in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Stepan’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stepan's specialty products — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stepan's specialty products — operating income?
Stepan (SCL) reported specialty products — operating income of $4.72M in Q1 2026.
How has Stepan's specialty products — operating income changed year-over-year?
Stepan's specialty products — operating income decreased by 14.4% year-over-year, from $5.51M to $4.72M.
What is the long-term trend for Stepan's specialty products — operating income?
Over 4 years (2021 to 2025), Stepan's specialty products — operating income has grown at a 16.0% compound annual growth rate (CAGR), from $14.18M to $25.64M.
What does specialty products — operating income mean?
This is the profit or loss generated by the Specialty Products segment after deducting both cost of goods sold and operating expenses from revenue. It is a key measure of the segment's core operational profitability and its contribution to the overall company's financial performance.